Weight loss medications like Ozempic and Wegovy have become increasingly popular over the past few years. For those who are looking into using a weight loss drug, how fast they work often comes ...

Prices of Cancer Drugs Have Skyrocketed Median 30-day cost for cancer drugs at time of launch 2000 2005 2010 2015 2020 0 10 20 $30K $24.6K ...

Microdosing isn’t just popular for psychedelics. Some consumers are taking smaller than standard doses of GLP-1s—the popular class of weight-loss and diabetes drugs that include Ozempic ...

Merit Medical Systems has acquired US-based Biolife Delaware, a manufacturer of haemostatic devices, in a $120m deal. The transaction value was paid in cash alongside the assumption of Biolife's ...

Weight loss drugs have become an increasingly popular, but controversial, way of quickly shedding extra pounds over the past few years. Part of that controversy deals with the side effects caused ...

Weight loss drugs have transformed how Americans lose weight, including former commissioner for the U.S. Food and Drug Administration Dr. David Kessler.

Background Non-variceal upper gastrointestinal bleeding (NVUGIB) remains a major cause of morbidity and mortality. Rebleeding rates following endoscopic treatment can reach up to 25% within 72 hours ...

GLP-1 drugs made a former FDA chief ‘feel ill.’ But he’d take them again. David Kessler has lost more than 60 pounds on weight-loss drugs and believes they can change the trajectory of ...

Injectable GLP-1 drugs are shot into subcutaneous fat and released slowly into the bloodstream, whereas pills are ingested and must avoid being broken down in the gastrointestinal tract.

The executive order directs the Food and Drug Administration to improve the process by which states can apply to import lower-cost drugs from Canada. In his first term, Mr. Trump created a pathway ...

Prices for complex generic drugs made for cancer would increase even more. ING said price hikes for a six-month supply of a generic cancer drug could cost people $8,000 to $10,000 more.

Good haemostatic efficacy, defined as haematoma expansion of ≤35% or ≤6 mL, was the primary outcome. Secondary efficacy outcomes were excellent haemostatic efficacy (≤20% haematoma expansion) and good ...